Effect of Endoscopic Sphincterotomy for Suspected Sphincter of Oddi Dysfunction on Pain-Related Disability Following Cholecystectomy The EPISOD Randomized Clinical Trial

被引:155
作者
Cotton, Peter B. [1 ]
Durkalski, Valerie [1 ]
Romagnuolo, Joseph [1 ]
Pauls, Qi [1 ]
Fogel, Evan [2 ]
Tarnasky, Paul [3 ]
Aliperti, Giuseppe [4 ]
Freeman, Martin [5 ]
Kozarek, Richard [6 ]
Jamidar, Priya [7 ]
Wilcox, Mel [8 ]
Serrano, Jose [9 ]
Brawman-Mintzer, Olga [10 ]
Elta, Grace [11 ]
Mauldin, Patrick [1 ]
Thornhill, Andre [1 ]
Hawes, Robert [1 ,12 ]
Wood-Williams, April [1 ]
Orrell, Kyle [1 ]
Drossman, Douglas [13 ,14 ]
Robuck, Patricia [9 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Dallas Med Ctr, Dallas, TX USA
[4] Midwest Therapeut Endoscopy Consultants, St Louis, MO USA
[5] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[6] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[7] Yale Univ, New Haven, CT USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA
[10] Ralph H Johnson VA Med Ctr, Charleston, SC USA
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Florida Hosp, Orlando, FL USA
[13] Univ N Carolina, Chapel Hill, NC USA
[14] Drossman Gastroenterol PLLC, Chapel Hill, NC USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 20期
关键词
FUNCTIONAL GASTROINTESTINAL DISORDERS; FINDINGS TYPE-I; HEALTH-STATUS; RISK-FACTORS; ERCP; GALLBLADDER; SYMPTOMS; BILIARY; PRESENTATIONS; COMPLICATIONS;
D O I
10.1001/jama.2014.5220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Abdominal pain after cholecystectomy is common and may be attributed to sphincter of Oddi dysfunction. Management often involves endoscopic retrograde cholangiopancreatography (ERCP) with manometry and sphincterotomy. OBJECTIVE To determine whether endoscopic sphincterotomy reduces pain and whether sphincter manometric pressure is predictive of pain relief. DESIGN, SETTING, AND PATIENTS Multicenter, sham-controlled, randomized trial involving 214 patients with pain after cholecystectomy without significant abnormalities on imaging or laboratory studies, and no prior sphincter treatment or pancreatitis randomly assigned (August 6, 2008-March 23, 2012) to undergo sphincterotomy or sham therapy at 7 referral medical centers. One-year follow-up was blinded. The final follow-up visit was March 21, 2013. INTERVENTIONS After ERCP, patients were randomized 2: 1 to sphincterotomy (n = 141) or sham (n = 73) irrespective of manometry findings. Those randomized to sphincterotomy with elevated pancreatic sphincter pressures were randomized again (1: 1) to biliary or to both biliary and pancreatic sphincterotomies. Seventy-two were entered into an observational study with conventional ERCP managemeny. MAIN OUTCOMES AND MEASURES Success of treatment was defined as less than 6 days of disability due to pain in the prior 90 days both at months 9 and 12 after randomization, with no narcotic use and no further sphincter intervention. RESULTS Twenty-seven patients (37%; 95% CI, 25.9%-48.1%) in the sham treatment group vs 32 (23%; 95% CI, 15.8%-29.6%) in the sphincterotomy group experienced successful treatment (adjusted risk difference, -15.6%; 95% CI, -28.0% to -3.3%; P =.01). Of the patients with pancreatic sphincter hypertension, 14 (30%; 95% CI, 16.7%-42.9%) who underwent dual sphincterotomy and 10 (20%; 95% CI, 8.7%-30.5%) who underwent biliary sphincterotomy alone experienced successful treatment. Thirty-seven treated patients (26%; 95% CI, 19%-34%) and 25 patients (34%; 95% CI, 23%-45%) in the sham group underwent repeat ERCP interventions (P =.22). Manometry results were not associated with the outcome. No clinical subgroups appeared to benefit from sphincterotomy more than others. Pancreatitis occurred in 15 patients (11%) after primary sphincterotomies and in 11 patients (15%) in the sham group. Of the nonrandomized patients in the observational study group, 5 (24%; 95% CI, 6%-42%) who underwent biliary sphincterotomy, 12 (31%; 95% CI, 16%-45%) who underwent dual sphincterotomy, and 2 (17%; 95% CI, 0%-38%) who did not undergo sphincterotomy had successful treatment. CONCLUSIONS AND RELEVANCE In patients with abdominal pain after cholecystectomy undergoing ERCP with manometry, sphincterotomy vs sham did not reduce disability due to pain. These findings do not support ERCP and sphincterotomy for these patients.
引用
收藏
页码:2101 / 2109
页数:9
相关论文
共 40 条
[21]   Impact of sexual and physical abuse dimensions on health status: Development of an abuse severity measure [J].
Leserman, J ;
Li, ZM ;
Drossman, DA ;
Toomey, TC ;
Nachman, G ;
Glogau, L .
PSYCHOSOMATIC MEDICINE, 1997, 59 (02) :152-160
[22]   Incidence of persistent symptoms after laparoscopic cholecystectomy: A prospective study [J].
Luman, W ;
Adams, WH ;
Nixon, SN ;
Mcintyre, IM ;
HamerHodges, D ;
Wilson, G ;
Palmer, KR .
GUT, 1996, 39 (06) :863-866
[23]   MULTIPLE TESTING PROCEDURE FOR CLINICAL-TRIALS [J].
OBRIEN, PC ;
FLEMING, TR .
BIOMETRICS, 1979, 35 (03) :549-556
[24]   Long-term outcome of endoscopic-dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram [J].
Park, SH ;
Watkins, JL ;
Fogel, EL ;
Sherman, S ;
Lazzell, L ;
Bucksot, L ;
Lehman, GA .
GASTROINTESTINAL ENDOSCOPY, 2003, 57 (04) :483-491
[25]   There is no role for ERCP in unexplained abdominal pain of pancreatic or biliary origin [J].
Pasricha, PJ .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (06) :S267-S272
[26]   Sphincter of Oddi dysfunction, part 2: evidence-based review of the presentations, with "objective" pancreatic findings (types I and II) and of presumptive type III [J].
Petersen, BT .
GASTROINTESTINAL ENDOSCOPY, 2004, 59 (06) :670-687
[27]   An evidence-based review of sphincter of Oddi dysfunction: part I, presentations with "objective" biliary findings (types I and II) [J].
Petersen, BT .
GASTROINTESTINAL ENDOSCOPY, 2004, 59 (04) :525-534
[28]   A comprehensive review of the placebo effect: Recent advances and current thought [J].
Price, Donald D. ;
Finniss, Damien G. ;
Benedetti, Fabrizio .
ANNUAL REVIEW OF PSYCHOLOGY, 2008, 59 :565-590
[29]   Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease [J].
Rana, JS ;
Mannam, A ;
Donnell-Fink, L ;
Gervino, EV ;
Sellke, FW ;
Laham, RJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12) :1456-1459
[30]   Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? [J].
Romagnuolo, Joseph ;
Cotton, Peter B. ;
Durkalski, Valerie ;
Pauls, Qi ;
Brawman-Mintzer, Olga ;
Drossman, Douglas A. ;
Mauldin, Patrick ;
Orrell, Kyle ;
Williams, April W. ;
Fogel, Evan L. ;
Tarnasky, Paul R. ;
Aliperti, Giuseppe ;
Freeman, Martin L. ;
Kozarek, Richard A. ;
Jamidar, Priya A. ;
Wilcox, C. Mel ;
Serrano, Jose ;
Elta, Grace H. .
GASTROINTESTINAL ENDOSCOPY, 2014, 79 (05) :765-772